Powers Advisory Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$279K Sell
11,579
-1,935
-14% -$50.6K 0.09% 110
2026
Q1
$379K Buy
13,514
+116
+0.9% +$3.09K 0.13% 88
2025
Q4
$334K Buy
13,398
+258
+2% +$6.51K 0.13% 93
2025
Q3
$335K Sell
13,140
-268
-2% -$6.62K 0.13% 90
2025
Q2
$325K Sell
13,408
-537
-4% -$12.5K 0.14% 90
2025
Q1
$353K Buy
13,945
+7
+0.1% +$183 0.17% 78
2024
Q4
$370K Sell
13,938
-32
-0.2% -$868 0.19% 76
2024
Q3
$404K Sell
13,970
-86
-0.6% -$2.51K 0.2% 69
2024
Q2
$393K Buy
14,056
+560
+4% +$15.4K 0.21% 67
2024
Q1
$375K Buy
13,496
+551
+4% +$15.3K 0.21% 69
2023
Q4
$373K Sell
12,945
-814
-6% -$24.6K 0.23% 65
2023
Q3
$456K Buy
13,759
+329
+2% +$11.6K 0.31% 59
2023
Q2
$493K Buy
13,430
+657
+5% +$25.6K 0.33% 56
2023
Q1
$521K Buy
12,773
+64
+0.5% +$2.76K 0.36% 54
2022
Q4
$651K Buy
12,709
+70
+0.6% +$3.36K 0.48% 46
2022
Q3
$553K Sell
12,639
-93
-0.7% -$4.52K 0.44% 49
2022
Q2
$668K Sell
12,732
-309
-2% -$15.7K 0.51% 45
2022
Q1
$675K Buy
13,041
+224
+2% +$11.6K 0.47% 51
2021
Q4
$757K Buy
+12,817
New +$635K 0.53% 46

Other funds holding PFE

Powers Advisory Group's PFE Position: Q2 2026 in Review

Powers Advisory Group reduced its Pfizer (PFE) stake by 14% in Q2 2026, selling an estimated $50.6K and leaving 11,579 shares worth $279K. The position accounts for 0.09% of the portfolio, ranked #110.

Powers Advisory Group first reported a position in PFE in Q4 2021 and has held it in 19 quarters since. The position peaked at $757K in Q4 2021. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Powers Advisory Group held 11,579 shares of Pfizer worth $279K as of Q2 2026.
  • Powers Advisory Group sold 1,935 Pfizer shares in Q2 2026, an estimated $50.6K.
  • Pfizer made up 0.09% of Powers Advisory Group's portfolio in Q2 2026, its #110 holding.
  • Powers Advisory Group first reported a position in Pfizer in Q4 2021 and has held it in 19 quarters since.
  • Powers Advisory Group's Pfizer position peaked at $757K in Q4 2021.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Powers Advisory Group's 13F filing for Q2 2026, filed 31 Jul 2026.